RxDoctor Payments Data

Richard Plowey, MD

Pain Medicine · Washington, PANPI 1154532612

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (56.6%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 29 manufacturers reported payments, led by Tersera Therapeutics LLC at 44.9% of the total. Reporting peaked in 2022 at $7,094 and has fallen 73.5% since, to $1,882 in 2025. Among pain medicine clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$20,740in general payments, 2019–2025

Across 384 payments — averaging $54.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Tersera Therapeutics LLC$9K
  • Abbott$5K
  • Medtronic$2K
  • Relievant Medsystems, Inc.$2K
  • Appliedvr Inc$567
  • SPR Therapeutics, Inc$515
  • plus $2K from 23 others

What the payments were for

  • Consulting fees$6,85233%
  • Travel & lodging$2,14810%
  • Food & beverage$11,74057%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$20,740 in reported general payments places this provider in the 90th percentile of 294 pain medicine providers in Pennsylvania.

See all pain medicine providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$290,494
Medicare patients
464
Services billed
12,817

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin72$838
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen75$824
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen48$506
Pregabalin11$457
Morphine Sulfate ErMorphine Sulfate16$431
Celecoxib13$183
Acetaminophen-CodeineAcetaminophen With Codeine12$111
Tramadol Hcl24$76
Oxycodone Hcl15$73
Methylprednisolone11$43

Paid to pharmacies, not to this prescriber.

Other pain medicine in Washington

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →